Key indicators: single-crystal X-ray study; T = 100 K; mean (C-C) = 0.006 Å; R factor = 0.035; wR factor = 0.092; data-to-parameter ratio = 13.0.
In the title compound, C 7 H 5 BrN 2 , fused six-membered pyridine and five-membered pyrrole rings form the essentially planar azaindole skeleton (r.m.s. deviation = 0.017 Å ). In the crystal, pairs of N-HÁ Á ÁN hydrogen bonds connect the molecules into inversion dimers.
Related literature
For the structure of 7-azaindole (C 7 H 6 N 2 ), see: Dufour et al. (1990) and for the structure of 3-iodo-7-azaindole (C 7 H 5 IN 2 ), see: Chou et al. (2000) . For the utilization of the title compound as the N-donor carrier ligand of highly cytotoxic platinum(II) dichlorido complexes, see: Š tarha et al. (2012) . Table 1 Hydrogen-bond geometry (Å , ).
Experimental
Symmetry code: (i) Àx þ 1; Ày þ 1; Àz þ 1.
Data collection: CrysAlis CCD (Oxford Diffraction, 2009); cell refinement: CrysAlis RED (Oxford Diffraction, 2009 ); data reduction: CrysAlis RED; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: DIAMOND (Brandenburg et al., 2011) ; software used to prepare material for publication: publCIF (Westrip, 2010 
Pavel Štarha and Zdeněk Trávníček Comment
The title compound 5-bromo-7-azaindole (5BrHaza), which is commercially available, was recently used, together with 3-chloro-7-azaindole and 3-iodo-7-azaindole, for the preparation of the platinum(II) dichlorido and oxalato (ox) complexes of the general formula cis-[PtCl 2 (nHaza) 2 ], and [Pt(ox)(nHaza) 2 ], respectively (Štarha et al., 2012) ; nHaza stands for the above-mentioned 7-azaindole halogeno-derivatives. The prepared Pt(II)-dichlorido complexes were found to be highly cytotoxic against the osteosarcoma (HOS), breast carcinoma (MCF7) and prostate carcinoma (LNCaP) human cancer cell lines. Particularly cis-[PtCl 2 (5BrHaza) 2 ] exceeded the clinically applied platinum-based anticancer drug cisplatin, (cis-[PtCl 2 (NH 3 ) 2 ]), since its IC 50 values (the concentration lethal for 50% of the tested cancer cells) equaled 2.5 µM (HOS; 34.2 µM for cisplatin), 2.0 µM (MCF7; 19.6 µM for cisplatin) and 1.5 µM (LNCaP; 3.8 µM for cisplatin).
The discrete molecules (Fig. 1 ) of the title compound contain fused six-membered pyridine and five-membered pyrrole rings forming the 7-azaindole skeleton. The planes fitted through the atoms of both rings form a dihedral angle of 2.09 (14)° (Fig. 2) . The most deviated atoms from the mentioned planes are C6 (-0.012 (4) Å) and C3 (-0.006 (4) Å), respectively, while the most deviated atom from the plane fitted through nonhydrogen atoms of the 7-azaindole moiety is C5 (0.025 (4) Å).
The crystal structure contains the N-H···N hydrogen bonds and C-H···C non-covalent contacts (Fig. 3) . Two N1-H1···N7 hydrogen bonds (Table 1) bind together two 5BrHaza molecules into a centrosymmetric dimer. The dimers are connected by C4-H4···C4 and C4-H···C5 non-covalent contacts (see Hydrogen-bond geometry) with four other dimers, which results in the formation of a 2D supramolecular array (Fig. 4) .
The molecular structure of the title compound resembles literature precedents: 7-azaindole (Dufour et al., 1990 ) and 3iodo-7-azaindole (Chou et al., 2000) .
Experimental
The title compound was employed as a starting compound of the syntheses of cis-[PtCl 2 (5BrHaza) 2 ] and [Pt(ox) Elemental analysis (C, H, N) was performed on a Thermo Scientific Flash 2000 CHNO-S Analyzer. The 1 H, 13 C and 15 N NMR spectra of the DMF-d 7 solutions were collected at 300 K on a Varian 400 spectrometer at 400.00 MHz, 100.58
MHz and 40.53 MHz, respectively. 1 H and 13 C spectra were calibrated using tetramethylsilane (TMS) as a reference. The 15 N NMR spectrum was measured relative to the DMF signals.
Refinement
Hydrogen atoms were located in difference maps and refined using the riding model with C-H = 0.95 Å and N-H = 0.88 Å, and with U iso (H) = 1.2U eq (CH, NH). The maximum and minimum residual electron density peaks of 1.69 and -0.33 eÅ -3 , respectively, were located 1.72 Å and 1.25 Å from the H6 and C6 atoms, respectively.
Computing details
Data collection: CrysAlis CCD (Oxford Diffraction, 2009); cell refinement: CrysAlis RED (Oxford Diffraction, 2009); data reduction: CrysAlis RED (Oxford Diffraction, 2009); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: DIAMOND (Brandenburg et al., 2011) ; software used to prepare material for publication: publCIF (Westrip, 2010) .
Figure 1
The molecular structure of the title compound with the non-hydrogen atoms depicted as displacement ellipsoids at the 50% probability level and given with the atom numbering scheme. Refinement. Refinement of F 2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on ALL data will be even larger.
5-Bromo-1H-pyrrolo[2,3-b]pyridine
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 ) (6) C8-N1-C2 107.6 (4) C4-C5-Br1 119.2 (3) C8-N1-H1 126.2 C6-C5-Br1 119.0 (3) C2-N1-H1 126.2 N7-C6-C5 123.1 (4) C3-C2-N1 110.6 (4) N7-C6-H6 118.4 C3-C2-H2 124.7 C5-C6-H6 118.4 N1-C2-H2 124.7 C6-N7-C8 114.9 (3) C2-C3-C7 107.0 (4) C4-C7-C3 136.6 (4) C2-C3-H3 126.5 C4-C7-C8 116.9 (4) C7-C3-H3 126.5 C3-C7-C8 106.4 (4) C5-C4-C7 116.9 (4) N7-C8-N1 125.4 (4) C5-C4-H4 121.5 N7-C8-C7 126.3 (4) C7-C4-H4 121.5 N1-C8-C7 108.3 (4) C4-C5-C6 121.8 (4) 
